TriGemX Bio and TCGX Acquisition file Form S-4, expect to close combination in Q1 2027

TriGemX Bio and TCGX Acquisition Corp. filed a Form S-4 for their combination. They expect to close the deal in Q1 2027 and trade on Nasdaq under the ticker symbol TGEM.

Detected & updated continuously · Source: Nebula